Connection

Bart Rijnders to Pyridones

Back to Details
This is a "connection" page, showing publications Bart Rijnders has written about Pyridones.
Bart Rijnders
Connection Strength
0.336
Pyridones
  1. Antiretroviral Monotherapy for HIV: Game Over or Future Perspectives? Clin Infect Dis. 2019 10 15; 69(9):1506-1508.
    View in: PubMed
    Score: 0.131
  2. Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial. Lancet HIV. 2017 12; 4(12):e547-e554.
    View in: PubMed
    Score: 0.114
  3. Reply to Darcis and Berkhout. J Infect Dis. 2018 11 05; 218(12):2020-2021.
    View in: PubMed
    Score: 0.031
  4. HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy. J Infect Dis. 2018 07 24; 218(5):688-697.
    View in: PubMed
    Score: 0.030
  5. The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors. J Infect Dis. 2018 07 24; 218(5):698-706.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.